Re: statins for kids- references to article

July 11, 2008

Here are the references to the article on heart health ( Time to get Scientific: let’s scrap the diet-heart-cholestrol hypothesis”, from CAM Magazine).

You can’t get the article online but I think we’ll transcribe it for everyone.

I’ll place the text below if the attachment won’t open.

E. Abrahamson, D.C.

Chiropractic physician

Lake Oswego Chiropractic Clinic

315 Second Street

Lake Oswego, OR 97034

503-635-6246

Website: http://www.lakeoswegochiro.com

From: Sharron Fuchs <sharronf@...>

Date: Thu, 10 Jul 2008 17:28:36 -0700

Abrahamson <drscott@...>

Conversation: statins for kids

Subject: RE: statins for kids

What article did you cite ? I missed it. –s-

References from article:

Time to get scientific: let's scrap the diet-heart-cholesterol hypothesis

Heart Disease - p38 of CAM March 2007:

References

1. Keys A. Atherosclerosis: A problem in newer public health. Journal of Mount Sinai Hospital 20, 118-139, 1953.

2. Reiser RA. A commentary on the rationale of the diet-heart statement of the American Heart Association. American Journal of Clinical Nutrition 40, 654-658, 1984.

3. Mann GV. Coronary heart disease: “Doing the wrong things.” Nutrition Today July/August, p. 12-14, 1985.

4. Rosch PJ. Statins don't work by lowering lipids. British Medical Journal 2001, 17.

5. Rosch PJ. Views on Cholesterol. Health and Stress. The Newsletter of The American Institute of Stress, volumes 1995: 1, 1998: 1, 1999: 8, 2001: 2,4,7.

6. Enig MG. Know Your Fats: The complete Primer for Understanding the Nutrition of Fats, oils, and Cholesterol. Bethesda Press, Silver Spring, MD, 2000.

7. Stehbens WE. The lipid hypothesis and the role of hemodynamics in atherogenesis. Progress in Cardiovascular Diseases. 33, 119-136, 1990.

8. RL. Diet, blood cholesterol and coronary heart disease: a critical review of the literature. Vector Enterprises. Vol 1, 1989; Vo.2, 1991.

9. Werko L. The enigma of coronary heart disease and its prevention. Acta Medica Scandinavica 221, 323-333, 1987.

10. Werko L Analysis of the MRFIT screenees: a methodological study. Journal of Internal Medicine 237, 507-518, 1995.

11. Pinckney ER and Pinckney C. The Cholesterol Controversy. Sherbourne Press. Los Angeles, 1973.

12. Ravnskov U. The cholesterol Myths. Exposing the fallacy that saturated fat and cholesterol cause heart disease. 2000. NewTrends Publishing.

13. Mann GV, Shaffer RD, Rich A. Physical fitness and immunity to heart disease in Masai. The Lancet 2, 1308-1310. 1965.

14. Shaper AG. Cardiovascular studies in the Samburu tribe of northern Kenya. American Heart Journal 63, 437-442, 1962.

15. Kannel WB, Gordon T. The Framingham diet study: diet and the regulation of serum cholesterol. The Framingham study. An Epidemiological Investigation of Cardiovascular Disease. Section 24. Washington, DC, 1970.

16. Taubes G. Nutrition: The soft science of dietary fat. Science magazine 292, 2536-2545, 2001.

17. Marmot MG et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Prevalence of coronary and hypertensive heart disease and associated risk factors. American Journal of Epidemiology 102, 514-525, 1975.

18. Oliver MF. Doubts about preventing coronary heart disease. Multiple interventions in middle-aged men may do more harm than good. British Medical Journal 304, 393-394, 1992.

19. Texon M. Hemodynamic basis for atherosclerosis with critique of the cholesterol-heart disease hypothesis. Begell House, New York 1995.

20. The Cholesterol Conspiracy. Warren H. Green, Inc. St. Louis, 1991.

21. Gould, K.L. “Very low-fat diets for coronary heart disease: Perhaps, but which one?” JAMA 275: 1402-1403 (1996).

22. Weidman WH et al. Nutrient intake and serum cholesterol level in normal children 6 to16 years of age. Pediatrics 61, 354-359, 1978.

23. Atrens DM. The questionable wisdom of a low-fat diet and cholesterol reduction. Social Science and Medicine 39, 433-447, 1994.

24. Nichols AB et al. Daily nutritional intake and serum lipid levels. The Tecumseh study. American Journal of Clinical Nutrition 29, 1384-1392, 1976.

25. JN et al. Diet and plasma cholesterol in 99 bank men. British Medical Journal 1, 571-576, 1963.

26. Marek Z et al. Atherosclerosis and levels of serum cholesterol in postmortem investigations. American Heart Journal 63, 768-774, 1962.

27. Apfelbaum M. Vivre avec du cholesterol. Editions du Rocher, Monaco 1992.

28. GD, Pekkanen J. Should there be a moratorium on the use of cholesterol lowering drugs? British Medical Journal 304, 431-434, 1992.

29. Berger M The cholesterol non-consensus. In: Somogyi JC, Biro G, Hotzel D (eds): Nutrition and Cardiovascular Risks. Bibliotheca Nutritio et Dieta nr 49, 125-130, 1992.

30. McGee CT. Heart Frauds. Uncovering the Biggest Health Scam in History. HealthWise, Colorado Springs 2001.

31. Ravnskov U. High cholesterol may protect against infections and atherosclerosis. Q J Med 2003;96:927-34.

32. Ravnskov U, Rosch PJ, Langsjoen PH, Kauffman JM, McCully KS. Evidence from the simvastatin trials that cancer is a probable long-term side effect. Unpublished letter to The Lancet.

33. Rosch PJ. Statin Associated Peripheral Neuropathy. Lancet, in press.

34. Golomb BA, Kane T, Dimsdale JE. Severe irritability associated with statin cholesterol-lowering drugs. Quart j M 2004;97:229-235.

35. Golomb BA. Statin adverse effects. Geriatric Times 2004;5.

36. Wagstaff LR, Mitton MW, Arvik BM, Doraiswamy PM. Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy 2003 Jul;23(7):871-80.

37. Edison RJ, Muenke. Central nervous system and limb anomalies in case reports of first-trimester statin exposure. N Engl J Med 2004;350:1579-1582.

38. Kendrick M. We are sleep-walking into what could become a major medical disaster because statin drugs will soon be sold over-the-counter. RedFlagsDaily June 17, 2004.

39. Rundek T, naini A, Sacco R, Coates K, KiMauro s. Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke. Arch Neurol. 2004;61:889-92.

40. Dam H, Sondergaard E. The encephalomalacia producing effect of arachidonic and linoleic acids. Zeitschrift fur Ernahrungswissenschaft 2, 217-222, 1962.

41. Richie J et al. Oedema and haemolytic anaemia in premature infants. New England Journal of Medicine 279, 1185-1190, 1968.

42. Pinckney ER. The potential toxicity of excessive polyunsaturates. Do not let the patient harm himself. American Heart Journal 85, 723-726, 1973.

43. West CE, Redgrave TG. Reservations on the use of polyunsaturated fats in human nutrition. Search 5, 90-96, 1974.

44. McHugh MI et al. Immunosuppression with polyunsaturated fatty acids in renal transplantation. Transplantation 24, 263-267, 1977.

45. JC, Valli VE, Chanin BE. Biological observations from feeding heated corn oil and heated peanut oil to rats. Journal of Toxicology and Environmental Health 21, 295-309, 1087.

46. Enig MG. Trans fatty acids in the food supply: a comprehensive report covering 60 years of research. Enig Associates, Inc., Silver Spring, MD, 1993.

47. Horrobin DF Lowering cholesterol concentrations and mortality. British Medical Journal 301, 554, 1990.

48. Golomb BA. Cholesterol and violence: is there a connection? ls of Internal Medicine 128, 478-487, 1998.

49. Koletzko B. Trans fatty acids may impair biosynthesis of long-chain polyunsaturates and growth in man. Acta Pediatrica 81, 302-306, 1992.

50. Gurr MI, AT. Lipid Biochemistry. 3rd Edition, England, Chapman and Hall, 1980.

51. Stryer L. Biochemistry, 3rd Edition. New York, NY. W.H. Freeman & Co. 1988.

52. Mensick RP, Katan MB. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. New England Journal of Medicine 323, 439-445, 1990.

53. Muldoon MF, Manuck SB, s KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. British Medical Journal 301, 554, 1990.

54. Lindberg G et al. Low serum cholesterol concentration and short term mortality from injuries in men and women. British Medical Journal 305, 277-279, 1992.

55. Editorial. Atherosclerosis and auto-oxidation of cholesterol. The Lancet 1, 964-965, 1980.

56. Steinberg D et al. Beyond cholesterol. Modification of low-density lipoprotein that increases its atherogenicity. New England Journal of Medicine 320, 915-924, 1989.

57. Iso H et al. Serum cholesterol levels and six-year mortality from stroke in 350,944 men screened for the multiple risk factor intervention trial. New England Journal of Medicine 320, 904-910, 1989.

58. Ravnskov U. Prevention of atherosclerosis in children. The Lancet 355, 69, 2000.

59. Castelli WP et al. Cardiovascular risk factors in the elderly. American Journal of Cardiology 63, 12H-19H, 1989.

60. Krumholz HM et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. Journal of the American Medical Association 272, 1335-1340, 1994.

61. Shestov DB et al. Increased risk of coronary heart disease death in men with low total and low-density-lipoprotein cholesterol in the Russian Lipid Research Clinics prevalence follow-up study. Circulation 99, 946-853.1993.

62. Forette B et al. Cholesterol as risk factor for mortality in elderly women. The Lancet 1, 868-870, 1989.

63. GC, Berenson GS, Webber LS. Dietary studies and the relationship of diet to cardiovascular disease risk factor variables in 10-year-old children - the Bogalusa heart study. The American Journal of Clinical Nutrition 31, 328-340, 1978.

64. Tuomilehto J, Kuulasmaa K. WHO MONICA Project: Assessing CHD mortality and morbidity. International Journal of Epidemiology 18, suppl. 1, S38-S45, 1989.

65. Esrey KL et al. Relationship between dietary intake and coronary heart disease mortality: Lipid Research Clinics prevalence follow-up study. Journal of Clinical Epidemiology 49, 211-216, 1996.

66. Sherwin RW et al. Serum cholesterol levels and cancer mortality in 361,662 men screened for the multiple risk factor intervention trial. Journal of the American Medical Association 257, 943-948, 1987.

67. Cowan LD et al. Cancer mortality and lipid and lipoprotein levels. The Lipid Research Clinics' program mortality follow-up study. American Journal of Epidemiology 131, 468-482, 1990.

68. Buchwald H et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the program on the surgical control of the hyperlipidemias (POSCH). New England Journal of Medicine 323, 946-955, 1990.

69. Data from 1986 FAO Production Yearbook 40, 1987; and World Health Statistics Annual, 1993.

70. Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol, 2001, 12: 105-112.

71. s D et al. Report of the conference on low blood cholesterol: Mortality associations. Circulation 86, 1046-1060, 1992.

72. Iribarren C et al. Serum total cholesterol and risk of hospitalisation and death from respiratory disease. International Journal of Epidemiology 26, 1191-1202, 1997.

73. Iribarren C et al. Cohort study of serum total cholesterol and in-hospital incidence of infectious diseases. Epidemiology and Infection 121, 335-347, 1998.

74. Claxton AJ et al. Association between serum total cholesterol and HIV infection in a high-risk cohort of young men. Journal of acquired immune deficiency syndromes and human retrovirology 17, 51-57, 1998.

75. Neaton JD, Wentworth DN. Low serum cholesterol and risk of death from AIDS. AIDS 11, 929-930, 1997.

76. Elias ER et al. Chlinical effects of cholesterol supplementation in six patients with the -Lemli-Opitz syndrome (SLOS). American Journal of Medical Genetics 68, 305-310, 1997.

77. Bhakdi S et al. Binding and partial inactivation of Staphylococcus aureus a-toxin by human plasma low density lipoprotein. Journal of Biological Chemistry 258, 5899-5904, 1983.

78. Muldoon MF et al. Immune system differences in men with hypo- or hypercholesterolemia. Clinical Immunology and Immunopathology 84, 145-149, 1997.

79. Graveline D. Lipitor - thief of memory, statin drugs and the misguided war on cholesterol. Infinity Publishing, Haverford, Pennsylvania.

80. Study suggests statins link to Parkinson's. Natural Products, Feb 2007, p6.

Also see this article:

http://www.totalbeing.com/news_archive_30_11_04.asp

July 11, 2008

Some of these are pretty old. If you are willing to get those articles I am willing to read them.

s. fuchs dc

From: Abrahamson [mailto:drscott@...] Sent: Friday, July 11, 2008 8:52 AMSharron Fuchs; orSubject: Re: statins for kids- references to article

Here are the references to the article on heart health ( Time to get Scientific: let’s scrap the diet-heart-cholestrol hypothesis”, from CAM Magazine).You can’t get the article online but I think we’ll transcribe it for everyone.I’ll place the text below if the attachment won’t open. E. Abrahamson, D.C.Chiropractic physicianLake Oswego Chiropractic Clinic315 Second StreetLake Oswego, OR 97034503-635-6246Website: http://www.lakeoswegochiro.com

From: Sharron Fuchs <sharronf@...>Date: Thu, 10 Jul 2008 17:28:36 -0700 Abrahamson <drscott@...>Conversation: statins for kidsSubject: RE: statins for kidsWhat article did you cite ? I missed it. –s- References from article:

Time to get scientific: let's scrap the diet-heart-cholesterol hypothesisHeart Disease - p38 of CAM March 2007:

References1. Keys A. Atherosclerosis: A problem in newer public health. Journal of Mount Sinai Hospital 20, 118-139, 1953. 2. Reiser RA. A commentary on the rationale of the diet-heart statement of the American Heart Association. American Journal of Clinical Nutrition 40, 654-658, 1984. 3. Mann GV. Coronary heart disease: “Doing the wrong things.” Nutrition Today July/August, p. 12-14, 1985. 4. Rosch PJ. Statins don't work by lowering lipids. British Medical Journal 2001, 17. 5. Rosch PJ. Views on Cholesterol. Health and Stress. The Newsletter of The American Institute of Stress, volumes 1995: 1, 1998: 1, 1999: 8, 2001: 2,4,7. 6. Enig MG. Know Your Fats: The complete Primer for Understanding the Nutrition of Fats, oils, and Cholesterol. Bethesda Press, Silver Spring, MD, 2000. 7. Stehbens WE. The lipid hypothesis and the role of hemodynamics in atherogenesis. Progress in Cardiovascular Diseases. 33, 119-136, 1990. 8. RL. Diet, blood cholesterol and coronary heart disease: a critical review of the literature. Vector Enterprises. Vol 1, 1989; Vo.2, 1991. 9. Werko L. The enigma of coronary heart disease and its prevention. Acta Medica Scandinavica 221, 323-333, 1987. 10. Werko L Analysis of the MRFIT screenees: a methodological study. Journal of Internal Medicine 237, 507-518, 1995. 11. Pinckney ER and Pinckney C. The Cholesterol Controversy. Sherbourne Press. Los Angeles, 1973. 12. Ravnskov U. The cholesterol Myths. Exposing the fallacy that saturated fat and cholesterol cause heart disease. 2000. NewTrends Publishing. 13. Mann GV, Shaffer RD, Rich A. Physical fitness and immunity to heart disease in Masai. The Lancet 2, 1308-1310. 1965. 14. Shaper AG. Cardiovascular studies in the Samburu tribe of northern Kenya. American Heart Journal 63, 437-442, 1962. 15. Kannel WB, Gordon T. The Framingham diet study: diet and the regulation of serum cholesterol. The Framingham study. An Epidemiological Investigation of Cardiovascular Disease. Section 24. Washington, DC, 1970. 16. Taubes G. Nutrition: The soft science of dietary fat. Science magazine 292, 2536-2545, 2001. 17. Marmot MG et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Prevalence of coronary and hypertensive heart disease and associated risk factors. American Journal of Epidemiology 102, 514-525, 1975. 18. Oliver MF. Doubts about preventing coronary heart disease. Multiple interventions in middle-aged men may do more harm than good. British Medical Journal 304, 393-394, 1992. 19. Texon M. Hemodynamic basis for atherosclerosis with critique of the cholesterol-heart disease hypothesis. Begell House, New York 1995. 20. The Cholesterol Conspiracy. Warren H. Green, Inc. St. Louis, 1991. 21. Gould, K.L. “Very low-fat diets for coronary heart disease: Perhaps, but which one?” JAMA 275: 1402-1403 (1996). 22. Weidman WH et al. Nutrient intake and serum cholesterol level in normal children 6 to16 years of age. Pediatrics 61, 354-359, 1978. 23. Atrens DM. The questionable wisdom of a low-fat diet and cholesterol reduction. Social Science and Medicine 39, 433-447, 1994. 24. Nichols AB et al. Daily nutritional intake and serum lipid levels. The Tecumseh study. American Journal of Clinical Nutrition 29, 1384-1392, 1976. 25. JN et al. Diet and plasma cholesterol in 99 bank men. British Medical Journal 1, 571-576, 1963. 26. Marek Z et al. Atherosclerosis and levels of serum cholesterol in postmortem investigations. American Heart Journal 63, 768-774, 1962. 27. Apfelbaum M. Vivre avec du cholesterol. Editions du Rocher, Monaco 1992. 28. GD, Pekkanen J. Should there be a moratorium on the use of cholesterol lowering drugs? British Medical Journal 304, 431-434, 1992. 29. Berger M The cholesterol non-consensus. In: Somogyi JC, Biro G, Hotzel D (eds): Nutrition and Cardiovascular Risks. Bibliotheca Nutritio et Dieta nr 49, 125-130, 1992. 30. McGee CT. Heart Frauds. Uncovering the Biggest Health Scam in History. HealthWise, Colorado Springs 2001. 31. Ravnskov U. High cholesterol may protect against infections and atherosclerosis. Q J Med 2003;96:927-34. 32. Ravnskov U, Rosch PJ, Langsjoen PH, Kauffman JM, McCully KS. Evidence from the simvastatin trials that cancer is a probable long-term side effect. Unpublished letter to The Lancet. 33. Rosch PJ. Statin Associated Peripheral Neuropathy. Lancet, in press. 34. Golomb BA, Kane T, Dimsdale JE. Severe irritability associated with statin cholesterol-lowering drugs. Quart j M 2004;97:229-235. 35. Golomb BA. Statin adverse effects. Geriatric Times 2004;5. 36. Wagstaff LR, Mitton MW, Arvik BM, Doraiswamy PM. Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy 2003 Jul;23(7):871-80. 37. Edison RJ, Muenke. Central nervous system and limb anomalies in case reports of first-trimester statin exposure. N Engl J Med 2004;350:1579-1582. 38. Kendrick M. We are sleep-walking into what could become a major medical disaster because statin drugs will soon be sold over-the-counter. RedFlagsDaily June 17, 2004. 39. Rundek T, naini A, Sacco R, Coates K, KiMauro s. Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke. Arch Neurol. 2004;61:889-92. 40. Dam H, Sondergaard E. The encephalomalacia producing effect of arachidonic and linoleic acids. Zeitschrift fur Ernahrungswissenschaft 2, 217-222, 1962. 41. Richie J et al. Oedema and haemolytic anaemia in premature infants. New England Journal of Medicine 279, 1185-1190, 1968. 42. Pinckney ER. The potential toxicity of excessive polyunsaturates. Do not let the patient harm himself. American Heart Journal 85, 723-726, 1973. 43. West CE, Redgrave TG. Reservations on the use of polyunsaturated fats in human nutrition. Search 5, 90-96, 1974. 44. McHugh MI et al. Immunosuppression with polyunsaturated fatty acids in renal transplantation. Transplantation 24, 263-267, 1977. 45. JC, Valli VE, Chanin BE. Biological observations from feeding heated corn oil and heated peanut oil to rats. Journal of Toxicology and Environmental Health 21, 295-309, 1087. 46. Enig MG. Trans fatty acids in the food supply: a comprehensive report covering 60 years of research. Enig Associates, Inc., Silver Spring, MD, 1993. 47. Horrobin DF Lowering cholesterol concentrations and mortality. British Medical Journal 301, 554, 1990. 48. Golomb BA. Cholesterol and violence: is there a connection? ls of Internal Medicine 128, 478-487, 1998. 49. Koletzko B. Trans fatty acids may impair biosynthesis of long-chain polyunsaturates and growth in man. Acta Pediatrica 81, 302-306, 1992. 50. Gurr MI, AT. Lipid Biochemistry. 3rd Edition, England, Chapman and Hall, 1980. 51. Stryer L. Biochemistry, 3rd Edition. New York, NY. W.H. Freeman & Co. 1988. 52. Mensick RP, Katan MB. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. New England Journal of Medicine 323, 439-445, 1990. 53. Muldoon MF, Manuck SB, s KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. British Medical Journal 301, 554, 1990. 54. Lindberg G et al. Low serum cholesterol concentration and short term mortality from injuries in men and women. British Medical Journal 305, 277-279, 1992. 55. Editorial. Atherosclerosis and auto-oxidation of cholesterol. The Lancet 1, 964-965, 1980. 56. Steinberg D et al. Beyond cholesterol. Modification of low-density lipoprotein that increases its atherogenicity. New England Journal of Medicine 320, 915-924, 1989. 57. Iso H et al. Serum cholesterol levels and six-year mortality from stroke in 350,944 men screened for the multiple risk factor intervention trial. New England Journal of Medicine 320, 904-910, 1989. 58. Ravnskov U. Prevention of atherosclerosis in children. The Lancet 355, 69, 2000. 59. Castelli WP et al. Cardiovascular risk factors in the elderly. American Journal of Cardiology 63, 12H-19H, 1989. 60. Krumholz HM et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. Journal of the American Medical Association 272, 1335-1340, 1994. 61. Shestov DB et al. Increased risk of coronary heart disease death in men with low total and low-density-lipoprotein cholesterol in the Russian Lipid Research Clinics prevalence follow-up study. Circulation 99, 946-853.1993. 62. Forette B et al. Cholesterol as risk factor for mortality in elderly women. The Lancet 1, 868-870, 1989. 63. GC, Berenson GS, Webber LS. Dietary studies and the relationship of diet to cardiovascular disease risk factor variables in 10-year-old children - the Bogalusa heart study. The American Journal of Clinical Nutrition 31, 328-340, 1978. 64. Tuomilehto J, Kuulasmaa K. WHO MONICA Project: Assessing CHD mortality and morbidity. International Journal of Epidemiology 18, suppl. 1, S38-S45, 1989. 65. Esrey KL et al. Relationship between dietary intake and coronary heart disease mortality: Lipid Research Clinics prevalence follow-up study. Journal of Clinical Epidemiology 49, 211-216, 1996. 66. Sherwin RW et al. Serum cholesterol levels and cancer mortality in 361,662 men screened for the multiple risk factor intervention trial. Journal of the American Medical Association 257, 943-948, 1987. 67. Cowan LD et al. Cancer mortality and lipid and lipoprotein levels. The Lipid Research Clinics' program mortality follow-up study. American Journal of Epidemiology 131, 468-482, 1990. 68. Buchwald H et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the program on the surgical control of the hyperlipidemias (POSCH). New England Journal of Medicine 323, 946-955, 1990. 69. Data from 1986 FAO Production Yearbook 40, 1987; and World Health Statistics Annual, 1993. 70. Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol, 2001, 12: 105-112. 71. s D et al. Report of the conference on low blood cholesterol: Mortality associations. Circulation 86, 1046-1060, 1992. 72. Iribarren C et al. Serum total cholesterol and risk of hospitalisation and death from respiratory disease. International Journal of Epidemiology 26, 1191-1202, 1997. 73. Iribarren C et al. Cohort study of serum total cholesterol and in-hospital incidence of infectious diseases. Epidemiology and Infection 121, 335-347, 1998. 74. Claxton AJ et al. Association between serum total cholesterol and HIV infection in a high-risk cohort of young men. Journal of acquired immune deficiency syndromes and human retrovirology 17, 51-57, 1998. 75. Neaton JD, Wentworth DN. Low serum cholesterol and risk of death from AIDS. AIDS 11, 929-930, 1997. 76. Elias ER et al. Chlinical effects of cholesterol supplementation in six patients with the -Lemli-Opitz syndrome (SLOS). American Journal of Medical Genetics 68, 305-310, 1997. 77. Bhakdi S et al. Binding and partial inactivation of Staphylococcus aureus a-toxin by human plasma low density lipoprotein. Journal of Biological Chemistry 258, 5899-5904, 1983. 78. Muldoon MF et al. Immune system differences in men with hypo- or hypercholesterolemia. Clinical Immunology and Immunopathology 84, 145-149, 1997. 79. Graveline D. Lipitor - thief of memory, statin drugs and the misguided war on cholesterol. Infinity Publishing, Haverford, Pennsylvania.80. Study suggests statins link to Parkinson's. Natural Products, Feb 2007, p6.Also see this article:http://www.totalbeing.com/news_archive_30_11_04.asp

July 11, 2008

I’ll get right to work on it.

Of course.

E. Abrahamson, D.C.

Chiropractic physician

Lake Oswego Chiropractic Clinic

315 Second Street

Lake Oswego, OR 97034

503-635-6246

Website: http://www.lakeoswegochiro.com

From: Sharron Fuchs <sharronf@...>

Date: Fri, 11 Jul 2008 12:43:37 -0700

or < >

Conversation: statins for kids- references to article

Subject: RE: statins for kids- references to article

Some of these are pretty old. If you are willing to get those articles I am willing to read them.

s. fuchs dc

From: Abrahamson [mailto:drscott@...]

Sent: Friday, July 11, 2008 8:52 AM

Sharron Fuchs; or

Subject: Re: statins for kids- references to article